Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of an orally delivered GLP-1 receptor agonist through peptide engineering and drug delivery to treat chronic disease
Sergei Pechenov, Jefferson D. Revell, Sarah Will, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zhikai Zheng, Zong Yao, Yiyang Ma, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 122
Recent advances in the development of therapeutic peptides
John Fetse, Sashi Kandel, Umar‐Farouk Mamani, et al.
Trends in Pharmacological Sciences (2023) Vol. 44, Iss. 7, pp. 425-441
Open Access | Times Cited: 45
Cell-penetrating peptides for transmucosal delivery of proteins
Jiamin Wu, Sophie Roesger, Natalie Jones, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 864-878
Closed Access | Times Cited: 20
Nonalcoholic fatty liver disease: Current therapies and future perspectives in drug delivery
Inês Domingues, Isabelle Leclercq, Ana Beloqui
Journal of Controlled Release (2023) Vol. 363, pp. 415-434
Closed Access | Times Cited: 30
Peptide-Mediated Nanocarriers for Targeted Drug Delivery: Developments and Strategies
Yubo Wang, Lu Zhang, Chen Liu, et al.
Pharmaceutics (2024) Vol. 16, Iss. 2, pp. 240-240
Open Access | Times Cited: 11
Optimized suction patch design for enhanced transbuccal macromolecular drug delivery
David Klein Cerrejon, Hanna Krupke, Daniel Gao, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 875-891
Open Access | Times Cited: 1
Molecular analysis and therapeutic applications of human serum albumin-fatty acid interactions
Sara Linciano, Giulia Moro, Alessandro Zorzi, et al.
Journal of Controlled Release (2022) Vol. 348, pp. 115-126
Closed Access | Times Cited: 36
Characterization and impact of peptide physicochemical properties on oral and subcutaneous delivery
Alisa Klepach, Huyen Tran, Faiz Ahmad Mohammed, et al.
Advanced Drug Delivery Reviews (2022) Vol. 186, pp. 114322-114322
Closed Access | Times Cited: 30
The Role of GLP1-RAs in Direct Modulation of Lipid Metabolism in Hepatic Tissue as Determined Using In Vitro Models of NAFLD
Ana G. Petrovic, Dunja Igrec, Karla Rožac, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 6, pp. 4544-4556
Open Access | Times Cited: 23
Advancing oral delivery of biologics: Machine learning predicts peptide stability in the gastrointestinal tract
Fanjin Wang, Nannapat Sangfuang, Laura E. McCoubrey, et al.
International Journal of Pharmaceutics (2023) Vol. 634, pp. 122643-122643
Open Access | Times Cited: 20
In Vivo Mechanism of Action of Sodium Caprate for Improving the Intestinal Absorption of a GLP1/GIP Coagonist Peptide
Huyen Tran, Eitaro Aihara, Faiz Ahmad Mohammed, et al.
Molecular Pharmaceutics (2023) Vol. 20, Iss. 2, pp. 929-941
Closed Access | Times Cited: 19
Oral delivery of biomacromolecules by overcoming biological barriers in the gastrointestinal tract: an update
Shiyun Liu, Xiangce Wen, Xin Zhang, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 10, pp. 1333-1347
Closed Access | Times Cited: 12
Challenges in Permeability Assessment for Oral Drug Product Development
Mirko Koziolek, Patrick Augustijns, Constantin Berger, et al.
Pharmaceutics (2023) Vol. 15, Iss. 10, pp. 2397-2397
Open Access | Times Cited: 11
Bioanalytical Methods and Strategic Perspectives Addressing the Rising Complexity of Novel Bioconjugates and Delivery Routes for Biotherapeutics
Ruipeng Mu, Jiaqi Yuan, Yue Huang, et al.
BioDrugs (2022) Vol. 36, Iss. 2, pp. 181-196
Open Access | Times Cited: 19
The link between hyperuricemia and diabetes: insights from a quantitative analysis of scientific literature
Lili Ma, Jing Wang, Li Ma, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Advances in Oral Biomacromolecule Therapies for Metabolic Diseases
Qiuxia Jiao, Yuan Huang, Jinhan He, et al.
Pharmaceutics (2025) Vol. 17, Iss. 2, pp. 238-238
Open Access
Post-synthetic Chemical Functionalization of Peptides
Stephanie A. Barros, Rosaura Padilla‐Salinas, Irini Abdiaj
Elsevier eBooks (2025)
Closed Access
A New Protractor Potentiates Glucagon-Like Peptide 1 with Slow-Release Depot and Long-Term Action
Jing Wang, Lei Peng, Shiwei Song, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Investigations of Enteric-Coated Tablet Propyl Gallate-Induced Nephrotoxicity in Beagles as well as Human and Dog Renal Proximal Tubule Epithelial Cells
Si Mou, B. Timothy Hummer, Jiaqi Yuan, et al.
ACS Pharmacology & Translational Science (2025)
Open Access
Design of potent and proteolytically stable double biaryl-stapled GLP-1R/GIPR peptide dual agonists
Yi‐Fang Yang, Qing Lin
Bioorganic & Medicinal Chemistry (2025) Vol. 125, pp. 118215-118215
Closed Access
Design and Biosynthesis of Ornithine 8-Containing Semaglutide Variants with a Click Chemistry-Modifiable Position 26
Yanli Xu, Oscar P. Kuipers
ACS Synthetic Biology (2025)
Closed Access
Pharmaceutical Analysis of Protein–Peptide Coformulations and the Influence of Polysorbates
Joseph Whiteley, Susanna Abrahmsén‐Alami, Jonathan Booth, et al.
Molecular Pharmaceutics (2025)
Open Access
Therapeutic peptides: chemical strategies fortify peptides for enhanced disease treatment efficacy
Qingmei Li, Chao Wen, Lijuan Qiu
Amino Acids (2025) Vol. 57, Iss. 1
Open Access
Progress and limitations of oral peptide delivery as a potentially transformative therapy
Huyen Tran, Mohamed E. H. ElSayed
Expert Opinion on Drug Delivery (2022) Vol. 19, Iss. 2, pp. 163-178
Closed Access | Times Cited: 15
Effect of Food Consumption on the Pharmacokinetics, Safety, and Tolerability of Once-Daily Orally Administered Orforglipron (LY3502970), a Non-peptide GLP-1 Receptor Agonist
Xiaosu Ma, Rong Liu, Edward Pratt, et al.
Diabetes Therapy (2024) Vol. 15, Iss. 4, pp. 819-832
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top